Cargando…

Controlling the Site Selectivity in Acylations of Amphiphilic Diols: Directing the Reaction toward the Apolar Domain in a Model Diol and the Midecamycin A(1) Macrolide Antibiotic

[Image: see text] Seeking to improve the site selectivity of acylation of amphiphilic diols, which is induced by imidazole-based nucleophilic catalysts and directs the reaction toward apolar sites, as we recently reported, we examined a new improved catalytic design and an alteration of the acylatin...

Descripción completa

Detalles Bibliográficos
Autores principales: Fallek, Reut, Ashush, Natali, Fallek, Amit, Fleischer, Or, Portnoy, Moshe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361358/
https://www.ncbi.nlm.nih.gov/pubmed/35801540
http://dx.doi.org/10.1021/acs.joc.2c00745
_version_ 1784764515962847232
author Fallek, Reut
Ashush, Natali
Fallek, Amit
Fleischer, Or
Portnoy, Moshe
author_facet Fallek, Reut
Ashush, Natali
Fallek, Amit
Fleischer, Or
Portnoy, Moshe
author_sort Fallek, Reut
collection PubMed
description [Image: see text] Seeking to improve the site selectivity of acylation of amphiphilic diols, which is induced by imidazole-based nucleophilic catalysts and directs the reaction toward apolar sites, as we recently reported, we examined a new improved catalytic design and an alteration of the acylating agent. The new catalysts performed slightly better selectivity-wise in the model reaction, compared to the previous set, but notably could be prepared in a much more synthetically economic way. The change of the acylating agent from anhydride to acyl chloride, particularly in combination with the new catalysts, accelerated the reaction and increased the selectivity in favor of the apolar site. The new selectivity-inducing techniques were applied to midecamycin, a natural amphiphilic antibiotic possessing a secondary alcohol moiety in each of its two domains, polar as well as apolar. In the case of the anhydride, a basic dimethylamino group, decorating this substrate, overrides the catalyst’s selectivity preference and forces selective acylation of the alcohol in the polar domain with a more than 91:1 ratio of the monoacylated products. To counteract the internal base influence, an acid additive was used or the acylating agent was changed to acyl chloride. The latter adjustment leads, in combination with our best catalyst, to the reversal of the ratio between the products to 1:11.
format Online
Article
Text
id pubmed-9361358
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-93613582022-08-10 Controlling the Site Selectivity in Acylations of Amphiphilic Diols: Directing the Reaction toward the Apolar Domain in a Model Diol and the Midecamycin A(1) Macrolide Antibiotic Fallek, Reut Ashush, Natali Fallek, Amit Fleischer, Or Portnoy, Moshe J Org Chem [Image: see text] Seeking to improve the site selectivity of acylation of amphiphilic diols, which is induced by imidazole-based nucleophilic catalysts and directs the reaction toward apolar sites, as we recently reported, we examined a new improved catalytic design and an alteration of the acylating agent. The new catalysts performed slightly better selectivity-wise in the model reaction, compared to the previous set, but notably could be prepared in a much more synthetically economic way. The change of the acylating agent from anhydride to acyl chloride, particularly in combination with the new catalysts, accelerated the reaction and increased the selectivity in favor of the apolar site. The new selectivity-inducing techniques were applied to midecamycin, a natural amphiphilic antibiotic possessing a secondary alcohol moiety in each of its two domains, polar as well as apolar. In the case of the anhydride, a basic dimethylamino group, decorating this substrate, overrides the catalyst’s selectivity preference and forces selective acylation of the alcohol in the polar domain with a more than 91:1 ratio of the monoacylated products. To counteract the internal base influence, an acid additive was used or the acylating agent was changed to acyl chloride. The latter adjustment leads, in combination with our best catalyst, to the reversal of the ratio between the products to 1:11. American Chemical Society 2022-07-08 2022-08-05 /pmc/articles/PMC9361358/ /pubmed/35801540 http://dx.doi.org/10.1021/acs.joc.2c00745 Text en © 2022 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Fallek, Reut
Ashush, Natali
Fallek, Amit
Fleischer, Or
Portnoy, Moshe
Controlling the Site Selectivity in Acylations of Amphiphilic Diols: Directing the Reaction toward the Apolar Domain in a Model Diol and the Midecamycin A(1) Macrolide Antibiotic
title Controlling the Site Selectivity in Acylations of Amphiphilic Diols: Directing the Reaction toward the Apolar Domain in a Model Diol and the Midecamycin A(1) Macrolide Antibiotic
title_full Controlling the Site Selectivity in Acylations of Amphiphilic Diols: Directing the Reaction toward the Apolar Domain in a Model Diol and the Midecamycin A(1) Macrolide Antibiotic
title_fullStr Controlling the Site Selectivity in Acylations of Amphiphilic Diols: Directing the Reaction toward the Apolar Domain in a Model Diol and the Midecamycin A(1) Macrolide Antibiotic
title_full_unstemmed Controlling the Site Selectivity in Acylations of Amphiphilic Diols: Directing the Reaction toward the Apolar Domain in a Model Diol and the Midecamycin A(1) Macrolide Antibiotic
title_short Controlling the Site Selectivity in Acylations of Amphiphilic Diols: Directing the Reaction toward the Apolar Domain in a Model Diol and the Midecamycin A(1) Macrolide Antibiotic
title_sort controlling the site selectivity in acylations of amphiphilic diols: directing the reaction toward the apolar domain in a model diol and the midecamycin a(1) macrolide antibiotic
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361358/
https://www.ncbi.nlm.nih.gov/pubmed/35801540
http://dx.doi.org/10.1021/acs.joc.2c00745
work_keys_str_mv AT fallekreut controllingthesiteselectivityinacylationsofamphiphilicdiolsdirectingthereactiontowardtheapolardomaininamodeldiolandthemidecamycina1macrolideantibiotic
AT ashushnatali controllingthesiteselectivityinacylationsofamphiphilicdiolsdirectingthereactiontowardtheapolardomaininamodeldiolandthemidecamycina1macrolideantibiotic
AT fallekamit controllingthesiteselectivityinacylationsofamphiphilicdiolsdirectingthereactiontowardtheapolardomaininamodeldiolandthemidecamycina1macrolideantibiotic
AT fleischeror controllingthesiteselectivityinacylationsofamphiphilicdiolsdirectingthereactiontowardtheapolardomaininamodeldiolandthemidecamycina1macrolideantibiotic
AT portnoymoshe controllingthesiteselectivityinacylationsofamphiphilicdiolsdirectingthereactiontowardtheapolardomaininamodeldiolandthemidecamycina1macrolideantibiotic